OBJECTIVE: To determine total body weight change occurring in women at mid-life, speci®cally with respect to occurrence of menopause and use of estrogen. DESIGN: Retrospective analysis of body weight measurements accumulated in two cohorts of healthy women participating in studies of skeletal metabolism. SUBJECTS: Cohort 1: 191 healthy nuns enrolled in a prospective study of osteoporosis risk, aged 35 ± 45 in 1967; cohort 2: 75 women aged 46 or older and still menstruating, enrolled in 1988 in a study of bone cell dynamics across menopause. Roughly one-third of each group received hormone replacement after menopause. MEASUREMENTS: Body weight and height, age, menstrual status and use of estrogen replacement. Cohort 1: 608 measurements at 5 y intervals spanning a period from 17 y before to 22 y after menopause; cohort 2: 1180 measurements at 6-month intervals spanning a period from 5 y prior to 5 y after menopause. RESULTS: In cohort 1 weight rose as a linear function of age (both chronological and menopausal), both before and after cessation of ovarian function, at a rate of $ 0.43% y
Introduction
While estrogen or hormone replacement therapy (ERTaHRT) after menopause is widely recommended, it remains true that fewer than half of women in North America who might bene®t from long-term HRT adhere to the therapy for more than a brief period of time. 1, 2 The reasons are many, but one, often cited, is the perception of gain in weight with HRT. 2 It has never been clear how restoring a lost hormone could produce weight gain that would not have occurred if hormone production had continued. Accordingly, explanation is sought in the transition itself. In other words, weight gain, it is said, occurs with the change from one hormonal state to another and, because of the dif®culty of shedding acquired weight, the transitions work like a ratchet. 3 Data supporting either the gain itself or the transitional ratcheting phenomenon are sparse. Crawford et al 4 in a 2.7 y longitudinal study of 324 women spanning menopause concluded that neither menopause itself nor the use of HRT had a detectable effect on weight. Other investigators 5 ± 8 have reported congruent ®ndings, but still others 9, 10 have reported an apparent weight gain with both transitions.
Few reported studies have had a suf®ciently long period of observation to establish the steady-state weight trajectories before and after the transitions, and for this reason the issue of what happens to body weight at the menopausal transition itself remains unclear. We report here observations of total body mass in two cohorts of women followed longitudinally across the menopausal transition, involving extended observations both pre-and postmenopausally.
Methods

Subjects
The studies from which our data come are as follows: cohort 1 denotes a prospective study of calcium metabolism and bone health at 5 y intervals in a group of 191 nuns from age 40 to age 70. 11 There were no exclusion factors for entrance into the original study, but for purposes of this analysis, weight data for persons with signi®cant intercurrent medical problems were eliminated. Cohort 2 denotes a study of bone remodeling dynamics and biochemical markers in a group of 75 healthy perimenopausal women observed at 6 month intervals over about 9 y. 12 Women with major health problems or taking bone-active drugs were excluded. These cohorts have been described in greater detail in their respective publications. 11, 12 Both projects had been reviewed and approved by Creighton University's Institutional Review Board, and all subjects gave written consent. Table 1 sets forth the pertinent anthropomorphic and personal information on the two groups. The women of cohort 2 differed signi®cantly from those of cohort 1, in that they were, on average, taller, heavier and older at menopause. The height difference is probably a secular cohort effect. The mean birth year for cohort 1 was 1926 and for cohort 2, 1939 . The mean stature difference between the cohorts was 2.4 cm, about what would be expected for this elapsed time difference. The difference in menopausal age is explained by the fact that, for the study for which they were recruited, the women of cohort 2 had to be at least 46 y old and still premenopausal on entry, while menopausal status was not a selection factor for cohort 1. Hence, by design, the left-hand end of the menopausal age distribution was truncated for cohort 2. The weight difference may be partly explained by parity. Cohort 1 was entirely nulliparous, while the women of cohort 2 had had an average of 3.05 children.
ERT or HRT decisions were made by the participants with their personal physicians, and were not in¯uenced or controlled by the investigators, except in cohort 2, in which participants were encouraged (not always successfully) to delay hormone replacement until the second bone biopsy could be obtained. For the most part, ERT was used in women without a uterus, and HRT in those with a uterus. No distinction is made in this analysis between the two forms of estrogen replacement, designated collectively as HRT'.
Measurements
In cohort 1 weight and height were measured while subjects were inpatients on a metabolic research unit, fasting, in the morning, wearing only pyjamas or nightgowns, using a beam balance scale. In cohort 2, weight and height were measured at varying times during the day, in light clothing and without shoes, using an electronic platform balance and a wall-mounted stadiometer. In both cohorts height is expressed in meters and weight in kilograms.
Data handling and analysis
The participants in cohort 1 were measured every 5 y, for a total of 608 observations extending over an average of $ 20 y each. The participants in cohort 2 were measured every 6 months, for a total of 1180 measurements extending over an average of $ 8 y each.
For the analysis in this paper, each of the participants in cohort 1 was required to have at least one visit before and at least one after menopause. Visit data were disquali®ed if the participant had an illness that affected weight. A total of 123 participants meeting those criteria are included here: 77 received no HRT at all; 29 went onto HRT without delay at menopause and stayed on it for various lengths of time; and 17 started HRT some years after menopause. Menopause was dated retrospectively as the calendar year in which menses ceased. Menopausal baseline weight values were determined by averaging weight data from the visits immediately before and after cessation of menstruation. These visits straddle menopause by about 2.5 y on either side.
In cohort 2 estrogen deprivation occurred for 55 women who reached menopause (determined retrospectively after 12 months without menses and the attaining of post-menopausal estradiol and FSH levels) and refrained from HRT for at least 1 y (until a transilial bone biopsy was performed). The data for one woman are discounted from this analysis because of irregular use of HRT. After the biopsy, some of the women chose to go on HRT. Twenty of the 75 women either reached last menses (LMP) naturally or surgically and immediately went on HRT or were still menstruating at the In order to remove the large component of interindividual variation and thus facilitate comparison of secular trends, weight in each woman was normalized to her weight at the time of her own menopause (or, in those women of cohort 2 who were estrogen-replete throughout the period of observation, to the average age at menopause of the other members of the cohort). Weight at each visit was divided by menopausal weight to obtain relative weight. In this way menopausal weight was given a value of 1.0, weights less than that at menopause, values less than 1.0, and weights greater, values above 1.0. Then these relative weights were aggregated across the group for each visit before or after the year of menopause in cohort 1 and before or after the date of LMP for cohort 2. The results are plotted as the time course of relative weight, with the origin of the time axis for each participant being set at the time of menopause and with the weight axis centered at the menopausal weight.
Simple descriptive statistics were used to characterize the baseline values in the two cohorts, and Student's t was used to compare them. The trend in weight over time was ®tted to a linear equation using standard least-squares regression methods. Figure 1 shows the time course of relative body mass in cohort 1, spanning a period from 17 y prior to menopause to 22 y after menopause, separated into three trajectories, two for those women who ultimately received ERTaHRT, and one for those who did not. The two ERTaHRT groups consist of those given replacement therapy promptly at time of menopause, and those started more than 3 y later. The three groups are plotted separately even before menopause on the possibility that those who accept or continue HRT might be different from those who do not. As can readily be seen, however, the three lines are essentially superimposable, both before and after the menopausal transition. Also, as is evident, there is no change in slope at the time of menopause for any of the three groups. The long-term slope for the total group is 0.00433, or a rate of gain of about 0.43% y 71 . At the average menopausal weight of the group, that slope translates to a long-term, steady state weight gain of $ 0.27 kg y 71 . Figure 2 presents the weight trajectories for cohort 2, showing a similar pattern, but with observations clustered much more closely around the time of menopause. As with cohort 1, separate lines are presented, one for those estrogenreplete throughout and the other for those who went through menopause and became estrogen-deprived. Both subgroups followed the same weight trajectory. As noted, this cohort was somewhat heavier than cohort 1, and their rate of gain prior to menopause was signi®cantly greater. As the ®gure suggests, the rate of gain slowed somewhat beginning $ 1 y prior to LMP. In both subsets, there was an Hormones, weight change and menopause KM Davies et al unexplained, abrupt, $ 3% weight loss that occurred at 2.5 ± 3.0 y after LMP, followed by a return to the prior trajectory by 4 y post menopause. Figure 3 takes the mean data of all the subjects of cohort 2 and superimposes it on a plot of the con®dence interval for the regression of relative weight on menopausal age for all the subjects of cohort 1, showing graphically that the two cohorts behaved identically after menopause. The downward blip' at 2 ± 3 y post menopause in cohort 2 may have been present as well in the subjects of cohort 1, but would not have been detected with a 5 y sampling interval. Whatever its basis or signi®cance, it is manifestly a transient phenomenon. 
Results
Discussion
To our knowledge, these data represent one of the longer periods of observation of weight change in mid-life women published to date, and thus they provide a ®rm basis both for estimating long-term secular trends and for interpreting the weight change experienced at menopause. To the extent that these two convenience samples can be generalized, what these longitudinal measurements show is that US women gain total body weight at an apparently linear rate from at least age 35 to at least age 65, and that neither loss of ovarian hormones nor their subsequent replacement produces a detectable change in this secular trend. Lovejoy, 3 in a review on this topic, described a 2 ± 5 pound weight gain across the menopausal transition. How many years that transition may have encompassed in the studies she summarized is uncertain, but if at least 5, such a gain would be consistent with the long-term trend we describe here, and thus the gain she speaks of would not be speci®cally menopausal. Svendsen et al, in a cross-sectional study of Danish women, 16 also found a progressive weight difference between ages 35 and 65, after adjusting for cohort height effects, amounting to a slope of 0.37% y 71 , essentially the same as our value of 0.43% y
71
. Moreover, Wang et al 17 noted that weight at mid-life was correlated positively with calendar age, not menopausal age, consistent with our conclusion that weight change is not speci®cally menopausal. Similarly, Wing et al 18 found no signi®cant difference in weight change in 485 middle-aged women over a 3 y period, whether or not they experienced menopause in the interim. Weight gain in their subjects averaged $ 0.7 kg y 71 , close to the rate we observed premenopause in cohort 2.
Many similar studies span only short periods of observation. Crawford et al, 4 who, like us, found no appreciable change at menopause, had only a 2.7 y period of observation, and hence could not establish the longer-term weight trajectory of their subjects.
It is important to stress that, as with any aggregate of human subjects, there was no single weight trajectory followed by all women. Some were losing weight, while others were gaining relatively rapidly. Some were consciously dieting, while others were not. Some changed their exercise pattern, while others did not. What the aggregated data reveal is the underlying trend around which the individual women were varying. The reason for the trend is uncertain. Some of it is probably biological, some of it environmental, and some of it behavioral. One possibility, suggested by Zemel et al, 13 relates to the low calcium intake typical of US women at mid-life. These investigators described an inverse correlation between calcium intake and body weight. We have con®rmed their observations in the two cohorts that are the subject of this report, to the effect that rate of weight gain is inversely proportional to calcium intake.
14 While calcium intake in these women accounted for only $ 3% of the variability in their weight change at mid-life, nevertheless the trend was signi®cantly less at higher calcium intakes. Average weight gain of zero is estimated to occur at calcium intakes in the range of current recommendations. 15 We cannot say with certainty why there is the reported perception of weight gain at menopause or with ERTaHRT. Possibly, augmented body awareness at that time, when other somatic changes are occurring, focuses attention on the background weight change and allows the attaching of one phenomenon to the other. Possibly also the bloating that may accompany progestin use (in HRT) may be a part of the explanation. Perhaps most likely, shifts in body fat distribution at mid-life 16, 17, 19 may contribute to a perception of total body weight gain. One inch at the waist is roughly equivalent to one dress size. It is known that estrogen deprivation augments the body fat shift to the waist area, 20 which could well explain a perception of weight gain at menopause, but estrogen reduces this shift, so body fat redistribution alone cannot explain a perception of weight gain with estrogen replacement.
The similarity of the trajectories of our two groups, despite their differing by 13 birth years, by mid-life body mass index (BMI), and by parity, coupled with now several other papers converging on the same point, 21, 22 make it unlikely that there is any real weight gain produced speci®-cally either by menopause or by ERTaHRT. If anything, as one of our two cohorts suggested, the menopausal transition appeared actually to slow somewhat the rate of gain in weight, rather than increase it.
